People gathered outside Portland City Hall Friday night, days after the 2024 presidential election. Read online: ...

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the Multicloud The Future of the Internet ...

“When we look at competition—and we are very respectful of them—some of the houses have been there for two centuries, some claim even more, but we are still in that phase where everything ...

As a prisoner in Nazi death camps during World War II, Lily Engelman vowed that—if she survived—she would one day bear witness to the systematic slaughter of Jewish people. After the war ...

This town may be in flux, but it’s still one of the greatest places on earth to earn a living. THR teamed up with Glassdoor ...

A reboot of Sylvester Stallone’s 1993 thriller ‘Cliffhanger’ will star Lily James and Pierce Brosnan Rocket Science;StudioCanal/Shutterstock Lily James is ...

A reboot of Sylvester Stallone’s action classic “Cliffhanger” is currently in production, but the film will look a lot different from the package initially announced nearly 18 months ago.

Emily in Paris star Lily Collins has told the BBC she is keen for an Emily in London spin-off as it "would be so fun". Collins, 35, has been living in London for the past few months while ...

Lilly's shares fall 8% as drug sales miss expectations CEO David Ricks cited physical and financial constraints at wholesalers for the shortfall Lilly slashes annual profit forecast due to ...

Copyright 2024 The Associated Press. All Rights Reserved. FILE - This April 26, 2017 file photo shows the Eli Lilly & Co. corporate headquarters in Indianapolis. (AP ...

Eli Lilly on Wednesday fell short of profit and revenue expectations for the third quarter, weighed down by disappointing sales of its blockbuster weight loss drug Zepbound and diabetes treatment ...

Eli Lilly and Company reported third quarter results and missed expectations and had to lower its guidance, which was a huge disappointment for investors. But in the last few years, Eli Lilly was ...